Back to User profile » Dr Jeng-Yuan Hsu

Papers published by Dr Jeng-Yuan Hsu:


Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study

Cheng SL, Ho ML, Lai YF, Wang HC, Hsu JY, Liu SF, Huang MS, Lee CH, Lin CH, Hang LW, Liu YC, Yang KY, Wang JH

Drug Design, Development and Therapy 2020, 14:5441-5450

Published Date: 8 December 2020

The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study

Hsieh MJ, Huang SY, Yang TM, Tao CW, Cheng SL, Lee CH, Kuo PH, Wu YK, Chen NH, Hsu WH, Hsu JY, Lin MS, Wang CC, Wei YF, Tsai YH

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2949-2959

Published Date: 25 September 2018

Wheezing, a significant clinical phenotype of COPD: experience from the Taiwan Obstructive Lung Disease Study

Huang WC, Tsai YH, Wei YF, Kuo PH, Tao CW, Cheng SL, Lee CH, Wu YK, Chen NH, Hsu WH, Hsu JY, Wang CC, Lin MS

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2121-2126

Published Date: 7 October 2015

Factors associated with the prescription of inhaled corticosteroids in GOLD group A and B patients with COPD – subgroup analysis of the Taiwan obstructive lung disease cohort

Wei YF, Kuo PH, Tsai YH, Tao CW, Cheng SL, Lee CH, Wu YK, Chen NH, Hsu WH, Hsu JY, Lin MS, Wang CC

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1951-1956

Published Date: 14 September 2015